Role of peptide radioimmunoassay in understanding peptidepeptide interactions and clinical expression of gastroenteropancreatic endocrine tumors
- 29 May 1987
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 82 (5) , 60-67
- https://doi.org/10.1016/0002-9343(87)90428-1
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Suppression of Gastrin and Gastric Acid Secretion in the Zollinger-Ellison Syndrome by Long-Acting Somatostatin (SMS 201-995)Scandinavian Journal of Gastroenterology, 1986
- The Response of a Non-Functional VIP- and Somatostatin-Containing Tumour to Tolbutamide in VitroScandinavian Journal of Gastroenterology, 1986
- Effect of a Long-Acting Somatostatin Analogue (SMS 201–995) in a Patient with Pancreatic CholeraNew England Journal of Medicine, 1985
- Substance P in the localization of a carcinoid tumorJournal of Surgical Oncology, 1984
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- THE EFFECT OF INCREASING DOSES OF INGESTED GLUCOSE ON INSULIN AND GASTRIC INHIBITORY POLYPEPTIDE (GIP) CONCENTRATIONS IN MANClinical Endocrinology, 1980
- PANCREATIC POLYPEPTIDE IN INSULINOMAS, GASTRINOMAS, VIPOMAS, AND GLUCAGONOMASThe Lancet, 1976
- Further Purification of Cholecystokinin and Pancreozymin.Acta Chemica Scandinavica, 1964
- PRELIMINARY COMMUNICATION ON THE CAUSATION OF THE SO-CALLED "PERIPHERAL REFLEX SECRETION" OF THE PANCREAS.The Lancet, 1902